![Henry Gosebruch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Henry Gosebruch
Directeur Général chez
LAKEFRONT BIOTHERAPEUTICS NV
Profil
Henry O.
Gosebruch is Chief Executive Officer & Executive Director at Lakefront Biotherapeutics since 2025.
Formerly, served as President, Chief Executive Officer & Director at Neumora Therapeutics, Inc. from 2023 to 2025.
Served as Independent Director at Aptinyx, Inc. from 2019 to 2023 and at ACELYRIN, Inc. from 2023 to 2025.
Worked at JPMorgan Securities LLC as Co-Head-Mergers & Acquisitions North America in 2015.
Served as Chief Strategy Officer & Executive Vice President at AbbVie, Inc. from 2015 to 2023.
Completed undergraduate degree at The Wharton School of the University of Pennsylvania in 1995.
Postes actifs de Henry Gosebruch
| Sociétés | Poste | Début |
|---|---|---|
| LAKEFRONT BIOTHERAPEUTICS NV | Directeur Général | 12/05/2025 |
Anciens postes connus de Henry Gosebruch
| Sociétés | Poste | Fin |
|---|---|---|
| ACELYRIN, INC. | Directeur/Membre du Conseil | 21/05/2025 |
| NEUMORA THERAPEUTICS, INC. | Directeur Général | 14/02/2025 |
| APTINYX | Directeur/Membre du Conseil | 04/05/2023 |
| ABBVIE INC. | Corporate Officer/Principal | 01/02/2023 |
JPMorgan Securities LLC
 JPMorgan Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01/12/2015 |
Formation de Henry Gosebruch
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
99
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
JPMorgan Securities LLC
JPMorgan Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Galapagos NV
 Galapagos NV BiotechnologyHealth Technology Manufactures and develops pharmaceutical products for oncology | Health Technology |
AbbVie, Inc.
 AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aptinyx, Inc.
 Aptinyx, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapies to treat disorders of the brain and nervous system | Health Technology |
ACELYRIN, Inc.
 ACELYRIN, Inc. Pharmaceuticals: MajorHealth Technology Operates as late-stage clinical biopharmaceutical company which focuses on identifying, acquiring and accelerating the development & commercialization of medicines | Health Technology |
Neumora Therapeutics, Inc.
 Neumora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops medicines for brain diseases | Health Technology |
